{"id":303500,"date":"2019-11-07T23:00:42","date_gmt":"2019-11-08T07:00:42","guid":{"rendered":"https:\/\/nai500.com\/?p=303500"},"modified":"2019-11-07T23:25:28","modified_gmt":"2019-11-08T07:25:28","slug":"%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e6%96%b0%e9%97%bb%e7%b2%be%e9%80%89","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/11\/%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e6%96%b0%e9%97%bb%e7%b2%be%e9%80%89\/","title":{"rendered":"\u533b\u7597\u4fdd\u5065\u65b0\u95fb\u7cbe\u9009"},"content":{"rendered":"<h4><strong>\u533b\u7597\u4fdd\u5065\u9886\u57df\u524d5<\/strong><strong>\u540d\u8d62\u5bb6\/<\/strong><strong>\u8f93\u5bb6<\/strong><\/h4>\n<ul>\n<li><strong>\u8d62\u5bb6\uff1a<\/strong><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=COLL\">Collegium Pharmaceutical (NASDAQ:COLL)<\/a> \uff0c\u6da831%\u3002<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=IVC\">Invacare (NYSE:IVC)<\/a> \uff0c\u6da829%\u3002<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=DXCM\">DexCom (NASDAQ:DXCM)<\/a> \uff0c\u6da829%\u3002<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=NVRO\">Nevro (NYSE:NVRO)<\/a> \uff0c\u6da826%\u3002<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=QTRX\">Quanterix (NASDAQ:QTRX)<\/a> \uff0c\u6da819%\u3002<\/li>\n<li><strong>\u8f93\u5bb6\uff1a<\/strong>Allena Pharmaceuticals (NASDAQ:ALNA) \uff0c\u8dcc49%\u3002ObsEva (NASDAQ:OBSV) \uff0c\u8dcc44%\u3002Sensus Healthcare (NASDAQ:SRTS) \uff0c\u8dcc28%\u3002Melinta Therapeutics (NASDAQ:MLNT) \uff0c\u8dcc27%\u3002EyePoint Pharmaceuticals (NASDAQ:EYPT) \uff0c\u8dcc25%\u3002<\/li>\n<\/ul>\n<h4><strong>Canopy Growth<\/strong><strong>\u5c06\u4e0e\u8bf4\u5531\u6b4c\u624bDrake<\/strong><strong>\u521b\u529e\u5927\u9ebb\u516c\u53f8\uff1b\u80a1\u4ef7\u4e0a\u6da82%<\/strong><\/h4>\n<ul>\n<li>Canopy Growth<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=CGC\"> (NYSE:CGC)<\/a>\u4e0e\u52a0\u62ff\u5927\u8bf4\u5531\u6b4c\u624bAubrey Drake Graham\u7b7e\u7f72\u534f\u8bae\uff0c\u6210\u7acb\u4e86More Life Growth Company\uff0c\u8fd9\u662f\u4e00\u5bb6\u5b8c\u5168\u8bb8\u53ef\u7684\u5927\u9ebb\u751f\u4ea7\u5546\uff0c\u603b\u90e8\u4f4d\u4e8eDrake\u7684\u5bb6\u4e61\u591a\u4f26\u591a\u3002<\/li>\n<li>\u6839\u636e\u4ea4\u6613\u6761\u6b3e\uff0cDrake\u5c06\u62e5\u6709More Life Growth Company\u768460%\u80a1\u4efd\uff0c\u800cCanopy\u5c06\u4fdd\u7559\u5176\u524d\u5168\u8d44\u5b50\u516c\u53f840%\u7684\u80a1\u4efd\uff0c\u5e76\u5c06\u8d1f\u8d23More Life\u8bbe\u65bd\u7684\u65e5\u5e38\u8fd0\u8425\u548c\u7ef4\u62a4\uff0c\u4ee5\u53ca\u5c06\u4fdd\u7559\u5728\u6b64\u5206\u9500\u6240\u79cd\u690d\u4ea7\u54c1\u7684\u6240\u6709\u6743\u5229\u3002<\/li>\n<\/ul>\n<h4><strong>\u7f8e\u8054\u50a8\u8d77\u8bc9\u5409\u5229\u5fb7<\/strong><strong>\u63a5\u89e6\u75c5\u6bd2\u524d\u9884\u9632\u6cbb\u7597<\/strong><strong>\u7684\u4e13\u5229<\/strong><\/h4>\n<ul>\n<li>\u7f8e\u56fd\u653f\u5e9c\u4ee3\u8868\u536b\u751f\u548c\u516c\u5171\u670d\u52a1\u90e8\uff08HHS\uff09\u63d0\u8d77\u8bc9\u8bbc\uff0c\u58f0\u79f0<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=GILD\">\u5409\u5229\u5fb7\u79d1\u5b66\uff08NASDAQ\uff1aGILD\uff09<\/a>\u7684\u836f\u54c1Truvada\u548cDescovy\u4fb5\u72af\u4e86\u4e0e\u63a5\u89e6\u75c5\u6bd2\u524d\u9884\u9632\u6cbb\u7597\uff08PrEP\uff09\u76f8\u5173\u7684HHS\u4e13\u5229\u3002<\/li>\n<li>HHS\u79d8\u4e66Alex Azar\u8bf4\uff1a\u201c HHS\u8ba4\u53ef\u5409\u5229\u5fb7\u5728\u5411\u60a3\u8005\u51fa\u552eTruvada\u548cDescovy\u4ee5\u9884\u9632\u827e\u6ecb\u75c5\u6bd2\u65b9\u9762\u7684\u4f5c\u7528\u3002\u793e\u533a\u5df2\u5c06\u8fd9\u4e9b\u836f\u7269\u7528\u4e8e\u633d\u6551\u751f\u547d\u548c\u51cf\u5c11\u827e\u6ecb\u75c5\u6bd2\u7684\u4f20\u64ad\u3002\u4f46\u662f\uff0c\u5409\u5229\u5fb7\u5fc5\u987b\u5c0a\u91cd\u7f8e\u56fd\u4e13\u5229\u5236\u5ea6\uff0c\u75be\u75c5\u9884\u9632\u63a7\u5236\u4e2d\u5fc3\u7814\u7a76\u4eba\u5458\u7684\u5f00\u521b\u6027\u5de5\u4f5c\u4ee5\u53ca\u7eb3\u7a0e\u4eba\u4e3a\u5f00\u53d1\u8fd9\u4e9b\u836f\u7269\u505a\u51fa\u7684\u5de8\u5927\u8d21\u732e\u3002\u4eca\u5929\u63d0\u8d77\u7684\u7533\u8bc9\u65e8\u5728\u786e\u4fdd\u4ed6\u4eec\u8fd9\u6837\u505a\u3002\u201d<\/li>\n<li>\u6839\u636eHHS\u7684\u8bf4\u6cd5\uff0cFDA\u6700\u521d\u6839\u636e\u75be\u75c5\u9632\u6cbb\u4e2d\u5fc3\u7684\u5de5\u4f5c\u6279\u51c6\u4e86\u7528\u4e8e\u6cbb\u7597HIV\u611f\u67d3\u7684\u836f\u7269\uff0c\u968f\u540e\u6279\u51c6\u4e86PrEP\u9002\u5e94\u75c7\u3002<\/li>\n<li>\u8be5\u516c\u53f8\u80a1\u7968\u5728\u76d8\u524d\u4ea4\u6613\u4e2d\u5c0f\u5e45\u4e0b\u8dcc\u3002<\/li>\n<\/ul>\n<h4><strong>\u68af\u74e6\u5728\u7f8e\u56fd\u63a8\u51fa<\/strong><strong>Rituxan<\/strong><strong>\u751f\u7269\u4eff\u5236\u836f<\/strong><\/h4>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=TEVA\">\u68af\u74e6\uff08NYSE\uff1aTEVA\uff09<\/a>\u548c\u5546\u4e1a\u5316\u5408\u4f5c\u4f19\u4f34Celltrion\u5ba3\u5e03\u5728\u7f8e\u56fd\u4e0a\u5e02\u4e0e<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=RHHBY\">\u7f57\u6c0f\uff08OTCQX\uff1aRHHBY\uff09<\/a>Rituxan\u7c7b\u4f3c\u7684\u751f\u7269\u4eff\u5236\u836fTruxima\uff08rituximab-abbs\uff09\u3002<\/li>\n<li>\u8fd9\u6b3e\u4eff\u5236\u836f\u7684\u6279\u53d1\u91c7\u8d2d\u6210\u672c\u5c06\u6bd4Rituxan\u4f4e10%\uff0c\u5206\u522b\u4e3a$845.55\/100\u6beb\u514b\u5c0f\u74f6\u88c5\u548c$4,227.75 \/ 500\u6beb\u514b\u88c5\u3002\u7531\u4e8eWAC\u4e0d\u8003\u8651\u989d\u5916\u7684\u56de\u6263\u548c\u6298\u6263\uff0c\u56e0\u6b64\u5b9e\u9645\u6210\u672c\u5e94\u66f4\u4f4e\u3002<\/li>\n<li>\u5728\u53d1\u5e03\u7b2c\u4e09\u5b63\u5ea6\u4e1a\u7ee9\u540e\uff0c\u68af\u74e6\u76d8\u524d\u4ef7\u683c\u4e0a\u6da8\u4e864%\u3002<\/li>\n<\/ul>\n<h4><strong>ObsEva<\/strong><strong>\u7684<\/strong><strong>Nolasiban<\/strong><strong>\u540e\u671f\u7814\u7a76\u5931\u8d25\uff0c\u8fde\u7d2f\u76d8\u524d\u80a1\u4ef7\u4e0b\u8dcc<\/strong><strong>24%<\/strong><\/h4>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=OBSV\">ObsEva SA (NASDAQ:OBSV)<\/a>\u6536\u76d8\u524d\u4e0b\u8dcc24%\uff0c\u539f\u56e0\u662f\uff0c\u8be5\u516c\u53f8\u5176\u5ba3\u5e03\u5148\u5bfc\u836f\u7269Nolasiban\u672a\u80fd\u57283\u671f\u4e34\u5e8a\u8bd5\u9a8cIMPLANT4\u4e2d\u8fbe\u5230\u4e3b\u8981\u7ec8\u70b9\uff0cIMPLANT4\u65e8\u5728\u8bc1\u660e\u5355\u6b21\u53e3\u670d\u5242\u91cf\u589e\u52a0\u4e86\u8fdb\u884c\u4f53\u5916\u53d7\u7cbe\uff08IVF\uff09\u7684\u5973\u6027\u7684\u6000\u5b55\u6bd4\u7387\u3002\u8be5\u516c\u53f8\u5df2\u51b3\u5b9a\u7ec8\u6b62\u5f00\u53d1IVF\u548c\u6b63\u5728\u63a2\u7d22\u201c\u91cd\u65b0\u5b9a\u4f4d\u201d\u7684\u50ac\u4ea7\u7d20\u53d7\u4f53\u62ee\u6297\u5242\u3002<\/li>\n<li>\u672c\u5b63\u5ea6\u5373\u5c06\u5230\u6765\u7684\u91cd\u8981\u91cc\u7a0b\u7891\uff1a\u6765\u81ea\u56e0\u5b50\u5bab\u808c\u7624\u5f15\u8d77\u7684\u6708\u7ecf\u5927\u91cf\u51fa\u8840\u7684\u5973\u6027\u76843\u671fPRIMROSE 2\u7814\u7a76\u4e2d\u6709\u5173Linzagolix\u7684\u516d\u4e2a\u6708\u4e3b\u8981\u7ec8\u70b9\u6570\u636e\u3002<\/li>\n<li>\u6765\u81ea\u65e9\u4ea7\u5148\u5146\u5987\u5973\u7684OBE22 2a\u671f\u7814\u7a76B\u90e8\u5206\u7684\u4e2d\u671f\u6570\u636e\u3002<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>\u533b\u7597\u4fdd\u5065\u9886\u57df\u524d5\u540d\u8d62\u5bb6\/\u8f93\u5bb6 \u8d62\u5bb6\uff1aCollegium Pharmaceutical (NASDAQ:COLL [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":303501,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[925,459],"class_list":["post-303500","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-925","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/303500","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=303500"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/303500\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/303501"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=303500"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=303500"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=303500"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}